Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...